328 related articles for article (PubMed ID: 27609016)
1. Gastric cancer: somatic genetics as a guide to therapy.
Zhang XY; Zhang PY
J Med Genet; 2017 May; 54(5):305-312. PubMed ID: 27609016
[TBL] [Abstract][Full Text] [Related]
2. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
Joo MK; Park JJ; Chun HJ
World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
[TBL] [Abstract][Full Text] [Related]
3. Current and emerging therapies in unresectable and recurrent gastric cancer.
Jou E; Rajdev L
World J Gastroenterol; 2016 May; 22(20):4812-23. PubMed ID: 27239108
[TBL] [Abstract][Full Text] [Related]
4. Recent advances and future trends in the targeted therapy of metastatic gastric cancer.
Al-Batran SE; Werner D
Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):555-69. PubMed ID: 24665840
[TBL] [Abstract][Full Text] [Related]
5. Advances of Molecular Targeted Therapy in Gastric Cancer.
Cetin B; Gumusay O; Cengiz M; Ozet A
J Gastrointest Cancer; 2016 Jun; 47(2):125-34. PubMed ID: 26875080
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of advanced gastric cancer: the role of new molecular drugs.
De Vita F; Di Martino N; Fabozzi A; Laterza MM; Ventriglia J; Savastano B; Petrillo A; Gambardella V; Sforza V; Marano L; Auricchio A; Galizia G; Ciardiello F; Orditura M
World J Gastroenterol; 2014 Oct; 20(40):14537-58. PubMed ID: 25356019
[TBL] [Abstract][Full Text] [Related]
7. Companion diagnostics for the targeted therapy of gastric cancer.
Yoo C; Park YS
World J Gastroenterol; 2015 Oct; 21(39):10948-55. PubMed ID: 26494953
[TBL] [Abstract][Full Text] [Related]
8. Targeting the hepatocyte growth factor/mesenchymal epithelial transition pathway in gastric cancer: biological rationale and clinical applications.
Abdel-Rahman O
Expert Rev Anticancer Ther; 2015 Feb; 15(2):235-45. PubMed ID: 25353620
[TBL] [Abstract][Full Text] [Related]
9. Efficacy prediction of targeted therapy for gastric cancer: The current status (Review).
Feng W; Zhu X
Mol Med Rep; 2018 Aug; 18(2):1238-1246. PubMed ID: 29901092
[TBL] [Abstract][Full Text] [Related]
10. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
11. Genetics of Gastric Cancer.
Strand MS; Lockhart AC; Fields RC
Surg Clin North Am; 2017 Apr; 97(2):345-370. PubMed ID: 28325191
[TBL] [Abstract][Full Text] [Related]
12. Personalized medicine in gastric cancer: Where are we and where are we going?
Jácome AA; Coutinho AK; Lima EM; Andrade AC; Dos Santos JS
World J Gastroenterol; 2016 Jan; 22(3):1160-71. PubMed ID: 26811654
[TBL] [Abstract][Full Text] [Related]
13. [Molecular targeting agents for advanced or recurrent gastric cancer patients].
Fuse N
Nihon Rinsho; 2012 Oct; 70(10):1819-26. PubMed ID: 23198568
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy in gastric cancer.
Thiel A; Ristimäki A
APMIS; 2015 May; 123(5):365-72. PubMed ID: 25706252
[TBL] [Abstract][Full Text] [Related]
15. A global burden of gastric cancer: the major impact of China.
Nie Y; Wu K; Yu J; Liang Q; Cai X; Shang Y; Zhou J; Pan K; Sun L; Fang J; Yuan Y; You W; Fan D
Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):651-661. PubMed ID: 28351219
[TBL] [Abstract][Full Text] [Related]
16. Molecular targeting to treat gastric cancer.
Aoyagi K; Kouhuji K; Kizaki J; Isobe T; Hashimoto K; Shirouzu K
World J Gastroenterol; 2014 Oct; 20(38):13741-55. PubMed ID: 25320512
[TBL] [Abstract][Full Text] [Related]
17. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
Fuchs CS; Tomasek J; Yong CJ; Dumitru F; Passalacqua R; Goswami C; Safran H; Dos Santos LV; Aprile G; Ferry DR; Melichar B; Tehfe M; Topuzov E; Zalcberg JR; Chau I; Campbell W; Sivanandan C; Pikiel J; Koshiji M; Hsu Y; Liepa AM; Gao L; Schwartz JD; Tabernero J;
Lancet; 2014 Jan; 383(9911):31-39. PubMed ID: 24094768
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapy for gastric cancer: molecular pathways and ongoing investigations.
Yang W; Raufi A; Klempner SJ
Biochim Biophys Acta; 2014 Aug; 1846(1):232-7. PubMed ID: 24858418
[TBL] [Abstract][Full Text] [Related]
19. Advanced HER2-positive gastric cancer: current and future targeted therapies.
Pazo Cid RA; Antón A
Crit Rev Oncol Hematol; 2013 Mar; 85(3):350-62. PubMed ID: 23021388
[TBL] [Abstract][Full Text] [Related]
20. The JAK/STAT signaling cascade in gastric carcinoma (Review).
Khanna P; Chua PJ; Bay BH; Baeg GH
Int J Oncol; 2015 Nov; 47(5):1617-26. PubMed ID: 26398764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
